Cargando…

The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners

Habitual endurance training may be associated with mild airway inflammation and subsequent deterioration in lung function. PCSO-524™ (Lyprinol®/Omega-XL®), a supplement extracted from the New Zealand green-lipped mussel (Perna canaliculus), has been shown to moderate airway inflammation in asthmatic...

Descripción completa

Detalles Bibliográficos
Autores principales: SHEI, REN-JAY, ADAMIC, EMILY M., CHAPMAN, ROBERT F., MICKLEBOROUGH, TIMOTHY D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Berkeley Electronic Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033491/
https://www.ncbi.nlm.nih.gov/pubmed/29997731
_version_ 1783337712059678720
author SHEI, REN-JAY
ADAMIC, EMILY M.
CHAPMAN, ROBERT F.
MICKLEBOROUGH, TIMOTHY D.
author_facet SHEI, REN-JAY
ADAMIC, EMILY M.
CHAPMAN, ROBERT F.
MICKLEBOROUGH, TIMOTHY D.
author_sort SHEI, REN-JAY
collection PubMed
description Habitual endurance training may be associated with mild airway inflammation and subsequent deterioration in lung function. PCSO-524™ (Lyprinol®/Omega-XL®), a supplement extracted from the New Zealand green-lipped mussel (Perna canaliculus), has been shown to moderate airway inflammation in asthmatic subjects. The purpose of this study was to determine whether supplementation with PCSO-524™ improves pulmonary and respiratory muscle function in non-asthmatic elite runners. Sixteen male, non-asthmatic elite runners were randomly assigned to either a treatment (PCSO-524™; 1 capsule contains 50 mg n-3 polyunsaturated fatty acids and 100 mg olive oil, n=8) or placebo (1 capsule contains 150 mg olive oil; n=8) group. During the supplementation period, subjects ingested 8 capsules of either treatment or placebo per day for 12 weeks. Resting pulmonary and respiratory muscle function testing were assessed at baseline and every two weeks throughout the 12 week supplementation period. No significant between-or within-subjects main effects were observed in forced vital capacity, forced expiratory volume in 1-second, forced expiratory flow from 25–75% of lung volume (FEF(25–75)), peak expiratory flow, maximal voluntary ventilation, maximal inspiratory mouth pressure, and closing volume (p>0.05). A significant within-subjects main effect was observed in maximal expiratory mouth pressure (P(Emax)) (p=0.024) and lung diffusion capacity (D(LCO)) (p<0.0001), but no significant between-subjects main effects were observed for P(Emax) and D(LCO) (p>0.05). A significant treatment by time interaction was observed in FEF(25–75) (p=0.026) and D(LCO) (p=0.024), but no other significant interactions were observed (all p>0.05). Supplementation with PCSO-524™ (Lyprinol®/Omega-XL®) does not improve pulmonary or respiratory muscle function in non-asthmatic elite runners.
format Online
Article
Text
id pubmed-6033491
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Berkeley Electronic Press
record_format MEDLINE/PubMed
spelling pubmed-60334912018-07-09 The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners SHEI, REN-JAY ADAMIC, EMILY M. CHAPMAN, ROBERT F. MICKLEBOROUGH, TIMOTHY D. Int J Exerc Sci Original Research Habitual endurance training may be associated with mild airway inflammation and subsequent deterioration in lung function. PCSO-524™ (Lyprinol®/Omega-XL®), a supplement extracted from the New Zealand green-lipped mussel (Perna canaliculus), has been shown to moderate airway inflammation in asthmatic subjects. The purpose of this study was to determine whether supplementation with PCSO-524™ improves pulmonary and respiratory muscle function in non-asthmatic elite runners. Sixteen male, non-asthmatic elite runners were randomly assigned to either a treatment (PCSO-524™; 1 capsule contains 50 mg n-3 polyunsaturated fatty acids and 100 mg olive oil, n=8) or placebo (1 capsule contains 150 mg olive oil; n=8) group. During the supplementation period, subjects ingested 8 capsules of either treatment or placebo per day for 12 weeks. Resting pulmonary and respiratory muscle function testing were assessed at baseline and every two weeks throughout the 12 week supplementation period. No significant between-or within-subjects main effects were observed in forced vital capacity, forced expiratory volume in 1-second, forced expiratory flow from 25–75% of lung volume (FEF(25–75)), peak expiratory flow, maximal voluntary ventilation, maximal inspiratory mouth pressure, and closing volume (p>0.05). A significant within-subjects main effect was observed in maximal expiratory mouth pressure (P(Emax)) (p=0.024) and lung diffusion capacity (D(LCO)) (p<0.0001), but no significant between-subjects main effects were observed for P(Emax) and D(LCO) (p>0.05). A significant treatment by time interaction was observed in FEF(25–75) (p=0.026) and D(LCO) (p=0.024), but no other significant interactions were observed (all p>0.05). Supplementation with PCSO-524™ (Lyprinol®/Omega-XL®) does not improve pulmonary or respiratory muscle function in non-asthmatic elite runners. Berkeley Electronic Press 2018-06-01 /pmc/articles/PMC6033491/ /pubmed/29997731 Text en
spellingShingle Original Research
SHEI, REN-JAY
ADAMIC, EMILY M.
CHAPMAN, ROBERT F.
MICKLEBOROUGH, TIMOTHY D.
The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
title The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
title_full The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
title_fullStr The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
title_full_unstemmed The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
title_short The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel (Perna canaliculus), on Pulmonary and Respiratory Muscle Function in Non-asthmatic Elite Runners
title_sort effects of pcso-524®, a patented marine oil lipid derived from the new zealand green lipped mussel (perna canaliculus), on pulmonary and respiratory muscle function in non-asthmatic elite runners
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033491/
https://www.ncbi.nlm.nih.gov/pubmed/29997731
work_keys_str_mv AT sheirenjay theeffectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT adamicemilym theeffectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT chapmanrobertf theeffectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT mickleboroughtimothyd theeffectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT sheirenjay effectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT adamicemilym effectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT chapmanrobertf effectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners
AT mickleboroughtimothyd effectsofpcso524apatentedmarineoillipidderivedfromthenewzealandgreenlippedmusselpernacanaliculusonpulmonaryandrespiratorymusclefunctioninnonasthmaticeliterunners